Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
49,065
Total Claims
$3.8M
Drug Cost
1,451
Beneficiaries
$2,634
Cost/Patient
Risk Score Breakdown 31/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,825 Geriatric Medicine providers
-54%
Opioid rate vs peers
1.2% vs 2.6% avg
+113%
Cost per patient vs peers
$2,634 vs $1,237 avg
+83%
Brand preference vs peers
16.8% vs 9.2% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.2%
Opioid Rate
576
Opioid Claims
$34K
Opioid Cost
26.6%
Long-Acting Rate
Brand vs Generic
Brand: 8,175 claims · $2.7M
Generic: 40,610 claims · $1.1M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,828 | $490K |
| Etanercept | 28 | $125K |
| Etanercept | 32 | $123K |
| Rivaroxaban | 427 | $111K |
| Fluticasone/Umeclidin/Vilanter | 204 | $106K |
| Interferon Beta-1a | 12 | $100K |
| Rifaximin | 59 | $95K |
| Sitagliptin Phosphate | 327 | $86K |
| Mirabegron | 358 | $83K |
| Valbenazine Tosylate | 19 | $72K |
| Empagliflozin | 239 | $70K |
| Dulaglutide | 101 | $67K |
| Pimavanserin Tartrate | 27 | $66K |
| Linagliptin | 203 | $52K |
| Insulin Glargine,hum.Rec.Anlog | 207 | $41K |
Prescribing Profile
Patient Profile
82
Avg Age
67%
Female
2.35
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About